Why Novavax Stock Is Jumping Today

Shares of Novavax (NASDAQ: NVAX) were 6.3% higher as of 10:56 a.m. EST on Monday after rising as much as 9.7% earlier in the day. This nice gain came after the biotech updated the progress of its COVID-19 vaccine development before the market opened.

Novavax stated that its late-stage study in the U.K. and its phase 2b study in South Africa of coronavirus vaccine candidate NVX-CoV2373 had completed enrollment. The company also said that its U.S./Mexico late-stage study is "expected to begin in the coming weeks." Novavax had previously stated this study would begin in November.

Image source: Getty Images.

Source Fool.com